Insulin-like growth factor (IGF) axis plays a paramount role in bone formation, maintenance of mineralized skeletons as well as the process of tooth formation
The SURMOUNT-1 trial showed average losses of 16 to 22.5% body weight over 72 weeks
All study participants were randomly assigned to an experimental treatment group that received subcutaneous injection of cagrilintide, once-weekly, in doses of either 0.3, 0.6, 1.2, 2.4, or 4.5 mg, as well as a one-daily 3.0 mg dose of liraglutide, and a volume matched placebo for control purposes
Similar to our original Myers Cocktail intravenous therapies, the Modified Myers IV therapy has a few added ingredients that can help, depending on your needs
Over the past ten years, GLP-1 receptor agonists (GLP-1RAs) such as Ozempic, Wegovy, and Mounjaro have taken the pharmaceutical world by storm
With this latest announcement, Sandoz is continuing to consistently implement its GLP-1 strategy